BVS vs HON · rev $573.3M vs P/E 36, rev $9.72B
Bioventus Inc (BVS) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
BVS currently screens at market cap $495.1M. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the BVS and HON stock pages for the full models.
Not investment advice.